生物活性 | |||
---|---|---|---|
描述 | Eriocitrin is a flavonoid isolated from lemon, which is a strong antioxidant agent. Eriocitrin could inhibit the proliferation of hepatocellular carcinoma cell lines by arresting cell cycle in S phase through up-regulation of p53, cyclin A, cyclin D3 and CDK6. Eriocitrin triggers apoptosis by activating mitochondria-involved intrinsic signaling pathway[3]. Eriocitrin attenuated oxidative injury and inflammatory response in rats with CI/R (cerebral ischemia reperfusion) via the Nrf2/HO-1/NQO1/NF-κB signaling pathway[4]. Oral administration of eriocitrin (32 mg/kg/day for 28 days) improved dyslipidaemia and decreased lipid droplets in the liver. In HepG2 cells, eriocitrin also induced the corresponding orthologues, and reduced lipid accumulation under conditions of lipid loading[5]. The 25 mg dose of eriocitrin had positive effects on oxidative stress, systemic inflammation and metabolism of lipids and glucose in general[6]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02627547 | Healthy | Not Applicable | Completed | - | United Kingdom ... 展开 >> University of Glasgow School of Medicine Glasgow, United Kingdom 收起 << |
NCT03482401 | Breast Cancer | Not Applicable | Active, not recruiting | June 1, 2019 | Spain ... 展开 >> Hospital General Universitario Reina Sofía Murcia, Spain, 30003 收起 << |
NCT03215043 | Pre Diabetes | Not Applicable | Recruiting | June 28, 2019 | Brazil ... 展开 >> Sao Paulo State University "Julio de Mesquita Filho", Faculdade de Ciências Farmacêuticas Recruiting Araraquara, Sao Paulo, Brazil, 14800-903 Contact: Thais B Cesar, Ph.D. +55 16 3301-6927 tcesar@fcfar.unesp.br 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.68mL 0.34mL 0.17mL |
8.38mL 1.68mL 0.84mL |
16.76mL 3.35mL 1.68mL |
参考文献 |
---|